In his Leaddiscovery blog Oct 5 last year, Dr Jon Goldhill notes
Invion 102 smoking cessation that the identification of biomarker reduction offers opportunity to amplify efficacy
A combination of Invion 102 plus NRT could see much higher quit rates
Dramatic reduction in number of cigarettes could have significant harm reduction consequences
Says that there is evidence of ERK1 blockade
may prevent development of lung cancer !
I would say somewhat premature is an understatement.
In his Leaddiscovery blog Oct 5 last year, Dr Jon Goldhill notes...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 12.5¢ | $15.62K | 118.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 213400 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 57707 | 2 |
View Market Depth
| Last trade - 14.46pm 20/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |